The Defense Logistics Agency (DLA) Troop Support Pacific awarded Alfresa Corporation, a Japan-based medical device and life sciences company, a single-award Indefinite Delivery Contract (IDC) with a ceiling value of $156,045.19. The contract, which does not have a set-aside designation, enables the DLA to rapidly procure a variety of medical reagents, laboratory equipment, diagnostic supplies, and preventive maintenance services to support U.S. military medical facilities in the Pacific region, including locations in Japan, Diego Garcia, and other overseas sites.
Alfresa Corporation holds multiple IDCs with the DLA Troop Support Pacific, with ceiling values ranging from $42,839 to $517,227. These IDCs, focused on providing medical supplies and services to the Pacific region, allow for the issuance of firm-fixed price delivery orders to meet both recurring and emergent requirements of U.S. military medical operations. The most recent IDC, awarded in August 2023, has a ceiling value of $173,202.16 and covers the supply of laboratory reagents and medical supplies through August 2024. The DLA also issued several delivery orders under the current IDC, valued between $4,519.71 and $12,531.19, for the provision of reagents, consumables, and equipment to U.S. Naval Hospital Yokosuka and other facilities in Japan. These contract vehicles support the DLA's mission to provide comprehensive logistics support to military healthcare operations in the Pacific region.
Generated 1/22/25, 12:49 AM